RxDoctor Payments DataLook up a doctor →

Arvin Narula, MD

Interventional Cardiology · San Diego, CANPI 1144535709

Payments from drug & device makers

$284,682in general payments, 2019–2025

Across 968 payments — averaging $294.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$93K
  • Shockwave Medical, Inc$73K
  • Janssen Research & Development, LLC$29K
  • Edwards Lifesciences$23K
  • Medtronic$16K
  • Abiomed$15K
  • plus $36K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring60$93,302
Shockwave Medical, Inc63$72,508
Janssen Research & Development, LLC4$28,554
Edwards Lifesciences81$23,489
Medtronic(2 entities)127$16,031
Abiomed43$14,906
Penumbra, Inc.29$10,574
Abbott118$4,815
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)68$3,965
Siemens Medical Solutions USA, Inc.9$2,052
Inari Medical, Inc.28$1,795
Philips North America LLC32$1,522
Livanova USA, Inc.1$1,400
Boston Scientific36$1,277
Terumo Medical Corporation7$987
AstraZeneca30$780
Cardiovascular Systems Inc.14$763
Novartis31$609
Endologix LLC1$498
Johnson & Johnson36$466
Cvrx, Inc.7$311
Biotronik Inc.11$294
Cathworks, Inc.4$222
Merck11$206
Sanofi-aventis U.S. LLC8$204
Regeneron Healthcare Solutions, Inc.6$186
Imperative Care, Inc6$180
Acutus Medical, Inc.1$170
Biosense Webster, Inc.2$167
Amgen9$159
Asahi Intecc USA, Inc.1$149
Bard Peripheral Vascular, Inc.6$145
EKOS Corporation1$139
Cordis US CORP.2$137
E.r. Squibb & Sons, L.L.C.3$128
Lexicon Pharmaceuticals, Inc.1$120
Cook Medical LLC4$113
Alnylam Pharmaceuticals Inc.6$106
ZOLL Circulation Inc1$98
Kiniksa Pharmaceuticals, Ltd.5$98
Actelion Pharmaceuticals US, Inc.12$95
Pfizer4$92
Heartflow, Inc.2$82
Tactile Systems Technology Inc5$80
Novo Nordisk4$78
Irhythm Technologies, Inc.2$72
Boehringer Ingelheim3$66
Reflow Medical Inc1$49
Cardiva Medical, Inc.3$49
Bayer3$47
Vifor Pharma, Inc.1$40
Daiichi Sankyo Inc.2$36
Fresenius USA Marketing, Inc.1$35
Esperion Therapeutics, Inc.2$34
Kestra Medical Technology Services, Inc.1$27
Angiodynamics, Inc.1$26
Recor Medical Inc1$25
United Therapeutics Corporation1$23
Gilead1$21
Altathera Pharmaceuticals LLC1$19

How this compares

$284,682 in reported general payments places this provider in the 90th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California →

Medicare billing

Part B allowed, 2024
$462,726
Medicare patients
1,217
Services billed
3,408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in San Diego

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →